Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced that Ron Peck, M.D., Chief Medical Officer, will participate in a fireside chat at the Goldman Sachs 41st Annual Global Healthcare Conference on Thursday, June 11 at 4:40 p.m. ET.
June 5, 2020
· 1 min read